Shree Ganesh Biotech India Ltd
₹0.48
as on
What are INDmoney investors doing with Shree Ganesh Biotech India shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
-13%
Searches for Shree Ganesh Biotech India on INDmoney have decreased by 13% over the last 30 days.
Average holding period of indmoney investors
443 days
INDmoney investors hold Shree Ganesh Biotech India shares for an average of 443 days.
Shree Ganesh Biotech India Stock Performance
as on September 15, 2026 at 9:31 pm IST
Day's Low
Day's High
₹0.47₹0.50
2.08%
Downside
4.17%
Upside
52 Week's Low
52 Week's High
₹0.47₹0.802.08%
Downside
66.67%
Upside
Shree Ganesh Biotech India share price movements today
- Previous Close
- ₹0.49
- Open
- ₹0.49
- Volume
- 8.23L
- Upper Circuit
- ₹0.58
- Lower Circuit
- ₹0.40
- Day's Low - High
- ₹0.47 - ₹0.50
- 52 Week Low - High
- ₹0.47 - ₹0.80
Shree Ganesh Biotech India Historical Returns
- 1 Month Return
- -3.92 %
- 3 Month Return
- -18.33 %
- 1 Year Return
- -37.97 %
- 3 Year Return
- -46.74 %
- 5 Year Return
- -92.85 %
Shree Ganesh Biotech India Fundamentals
as on September 15, 2026 at 4:01 pm IST
Market Cap
₹19.53 Cr
Return on Equity (ROE)
0.96
PE Ratio (TTM)
0Return on capital employed (ROCE)
1.32
Industry PE ratio
-
Beta (LTM)
0.4
P/B Ratio
0.34
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-272.73
EPS (TTM)
0Book Value
0Shree Ganesh Biotech India Technical Analysis
Track how Shree Ganesh Biotech India technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0 | Bullish |
CCI (20) | 125.54 | |
RSI (14) | 45.6 | Neutral |
Momentum (10) | 0 | Neutral |
ADI (14) | 21.45 | Neutral |
Ultimate Oscillator (7,14,28) | 42.45 | Neutral |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 0.48 | |
EMA (20) | 0.48 | |
VWMA (20) | 0.48 | |
SMA (50) | 0.49 | |
EMA (50) | 0.48 | |
SMA (200) | 0.49 | |
EMA (200) | 0.49 | |
KAMA (200) | 0.48 | |
DEMA (200) | 0.48 |
Shree Ganesh Biotech India Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Shree Ganesh Biotech India with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 19.53 | -18.57% | 0.00 | 2 | 4 | |
| NA | 12.17 | 21.22% | 0.00 | -1 | 21 | |
| NA | 16,911.25 | 23.08% | 0.00 | 187 | 2,275 | |
| NA | 650.18 | 0.17% | 0.62 | 29 | 235 | |
| NA | 309.06 | 7.3% | 0.63 | 17 | 202 |
Shree Ganesh Biotech India Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Shree Ganesh Biotech India Ltd Annual Profit & Loss
Figures in Rupees Crores
Shree Ganesh Biotech India Ltd Cash Flow
Figures in Rupees Crores
Shree Ganesh Biotech India Corporate Actions
View detailed summary of the earnings and dividend history of Shree Ganesh Biotech India.
Shree Ganesh Biotech India Ltd Earnings Results
Shree Ganesh Biotech India Ltd’s net profit fell -272.73% since last year same period to ₹0.57Cr in the Q1 2026-2027. On a quarterly growth basis, Shree Ganesh Biotech India Ltd has generated -280% fall in its net profits since last 3-months.
Read More about Earnings Results
Insights on Shree Ganesh Biotech India Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTFII Holding Unchanged
Foreign Institutions holdings remained unchanged at 1.42% of holdings in Jun 2026 quarter
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 98.58% of holdings in Jun 2026 quarter
- NO EFFECT
Against Peers
In the last 3 years, Avanti Feeds Ltd has given 75.4% return, outperforming this stock by 122.1%
- NO EFFECT
Against Peers
In the last 1 year, Venkys India Ltd has given 19.5% return, outperforming this stock by 57.5%
NEGATIVE IMPACTPrice Dip
In the last 7 days, Shree Ganesh Bio stock has moved down by -3.9%
About Shree Ganesh Biotech India Ltd
Revenue: ₹1.43Cr as on June 2026 (Q1 FY27)
Net Profit: ₹0.57Cr as on June 2026 (Q1 FY27)
Chairperson Name: Aman Patel
| Organisation | Shree Ganesh Biotech India Ltd |
| Industry | Pharmaceuticals |
| CEO | Aman Patel |
| E-voting on shares | Click here to vote |
FAQs
What is Shree Ganesh Biotech India share price today?
Shree Ganesh Biotech India share price today stands at ₹0.48 as on at the close of the market. Shree Ganesh Biotech India share today touched a day high of ₹0.5 and a low of ₹0.47.
What is the 52 week high and 52 week low range for Shree Ganesh Biotech India share?
Shree Ganesh Biotech India touched a 52 week high of ₹0.8 and a 52 week low of ₹0.47. Shree Ganesh Biotech India share price today i.e. is closed at ₹0.48, which is -40.00% down from its 52 week high and 2.13% up from its 52 week low.
What is Shree Ganesh Biotech India's market capitalisation today?
Shree Ganesh Biotech India market capitalisation is ₹19.53 Cr as on .
How to buy Shree Ganesh Biotech India shares?
To buy Shree Ganesh Biotech India shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 539470 or Shree Ganesh Biotech India Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Shree Ganesh Biotech India shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Shree Ganesh Biotech India trading volume today?
Shree Ganesh Biotech India trading volume is 8.23L as on . This means that 8.23L shares of Shree Ganesh Biotech India were bought and sold on the stock market during today's trading session.